South Georgia Capital’s Pfizer PFE Stock Holding History

South Georgia Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$6K	Sell	211 -4,110	-95%	-$132K	0.01%	152
2015 Q2	$137K	Sell	4,321 -211	-5%	-$6.88K	0.28%	38
2015 Q1	$150K	Sell	4,532 -2,214	-33%	-$70.4K	0.28%	40
2014 Q4	$199K	Sell	6,746 -737	-10%	-$21.1K	0.36%	37
2014 Q3	$210K	Buy	7,483 +3,372	+82%	+$94.6K	0.31%	40
2014 Q2	$116K	Sell	4,111 -10,118	-71%	-$288K	0.14%	70
2014 Q1	$434K	Sell	14,229 -27,615	-66%	-$823K	0.37%	50
2013 Q4	$1.22M	Buy	+41,844	New	+$1.22M	0.75%	40

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

South Georgia Capital's PFE Position: Q3 2015 in Review

South Georgia Capital reduced its Pfizer (PFE) stake by 95% in Q3 2015, selling an estimated $132K and leaving 211 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #152.

South Georgia Capital first reported a position in PFE in Q4 2013 and has held it in 8 quarters since. The position peaked at $1.22M in Q4 2013. 1,878 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

South Georgia Capital held 211 shares of Pfizer worth $6K as of Q3 2015.
South Georgia Capital sold 4,110 Pfizer shares in Q3 2015, an estimated $132K.
Pfizer made up 0.01% of South Georgia Capital's portfolio in Q3 2015, its #152 holding.
South Georgia Capital first reported a position in Pfizer in Q4 2013 and has held it in 8 quarters since.
South Georgia Capital's Pfizer position peaked at $1.22M in Q4 2013.
1,878 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.